Type 2 Diabetes

A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.

Tirzepatide's dual-action may significantly impact a person's weight management and blood glucose compared to GLP-1 receptor agonists like semaglutide.

Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.

Study shows that breastfeeding can provide diabetes inhibiting effects for over three years.

Insulin icodec is a novel once-weekly basal insulin analog for patients with type 2 diabetes.

Treating obstructive sleep apnea can decrease catecholamine, increase insulin sensitivity, and decrease pancreatic beta-cell apoptosis, leading to a lower risk of developing T2D.

Tethered combination therapy for type 2 diabetes could be more beneficial than two medications taken concurrently.

CREDENCE trial shows that canagliflozin, an SGLT2 inhibitor, lowers the risk of cardiovascular and renal events in patients with T2DM, regardless of prior history of heart failure. 

Additional benefits are observed with dose escalation of semaglutide for patients with type 2 diabetes.

Sexual health questionnaires can be used as an early detection tool for men's CVD, coronary heart disease, stroke, and T2D.